Owen Adams Catherine bought ACAD
March 24, 2026 · Form 4 insider transaction
Owen Adams Catherine bought 23,509 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,509
Price
$0.00
Total value
N/A
InsiderOwen Adams Catherine
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 24, 2026
Filing dateMarch 26, 2026
Shares owned after26,444
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.; Includes 2,935 shares of the Issuer's common stock acquired by the reporting person on May 15, 2025 pursuant to an employee stock purchase plan.